Image Credit: Genprex Announcement Genprex, Inc., a leading clinical-level gene therapy company aiming to develop and advance life-changing therapies for diabetes and cancer patients, has signed a definitive agreement for the sale and purchase of 377.780 shares of common stock at a buyout ...
Image Credit: Ferring Pharmaceuticals Announcement Ferring Pharmaceuticals confirmed that three abstracts focusing on ADSTILADRIN will be showcased at the 101st Annual Meeting of the Western Section of the American Urological Association (AUA) in Napa, to be held from November 2 to 6, 2025...
Image Credit: Wavelifesciences Announcement Wave Life Sciences Ltd, a leading clinical-level biotechnology company dedicated towards unveiling the broader spectrum of capability of RNA medicines to convert into a human health, have confirmed its positive activin E target engagement data. T...
Image Credit: Medtronic Announcement Medtronic, a popular medical technology leader, will inaugurate its first-ever digital healthcare innovation hub in Beijing, China. The hub is engineered to deliver an excellent ecosystem for testing and establishing the AI-fueled, data-oriented healthc...
Image Credit: Faeth Therapeutics Announcement Faeth Therapeutics, a leading clinical-level biotechnology company focusing on the advancement of specific therapies focusing on tumour metabolism, has declared one more advancement of its popular PIKTOR regimen in endometrial cancer. Additionally, t...
Announcement The bridgeBio Pharma’s in-progress investigational oral small molecule BBP-418, an under-development study to cure a particular form of limb-girdle muscular dystrophy, has entered a late-stage trial. Following this, the new drug application is planned to proceed by the first half...
Image Credit: Wikipedia Announcement In a recent meeting, the FDA stressed the importance of future planning and planned to add a ‘precheck’ step in the drug approval procedure to achieve pinpoint accuracy in drug selection. This discussion was led by the concern and the worst ...
Image Credit: www.bms.com Announcement The Evotec SE, honouring its smart neuroscience collaboration, has announced that the company has received the milestone (profit) payment worth US$25M from Bristol Myers Squibb on its scientific progress gained within this partnership. The payment wil...
Announcement In Lisbon’s Alfama district, in Chicago, the retiree calculated his specific budget as $350 for groceries, $55 healthcare supplement and $1,120 for rent and his US insurance is worth $847 monthly. The ‘free healthcare’ is definitely real, but not uniform or true to t...
Announcement The uniqueness of gene therapy for Huntington’s disease’s pivotal results is a new ray of hope for patients disappointed in the past few years. Though one expert is concerned about the communication of the results, which are building false expectations. It is said that few...
